Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.22.2.2
Income Taxes (Tables)
12 Months Ended
Jun. 30, 2022
Income Taxes [Abstract]  
Schedule of Comprehensive Income (Loss)

The components of net loss consist of the following (in thousands):

    

For the Years Ended

June 30, 

 

2022

 

2021

United States

$

(50,304)

$

(23,200)

Brazil

 

 

(13)

Total

$

(50,304)

$

(23,213)

Schedule of Components of Income Tax Expense (Benefit)

The components of the provision (benefit) for income taxes consist of the following (in thousands):

For the Years Ended

June 30, 

 

2022

 

2021

Current – Federal and state

$

$

Deferred – Federal

    

(9,051)

    

(55)

Deferred – State

 

 

Total

 

(9,051)

 

(55)

Change in valuation allowance

 

9,051

 

55

Income tax expense

$

$

Schedule of Deferred Tax Assets and Liabilities

The components of the Company’s deferred tax assets and liabilities are as follows (in thousands):

    

As of June 30, 

    

2022

2021

Deferred tax assets (liabilities):

Net operating loss

$

35,829

$

24,693

Share-based compensation

 

1,248

 

353

Research and development tax credits

 

1,764

 

1,737

Investment in equity security

370

Basis in iBio CDMO

 

 

984

Property, plant and equipment

(2,520)

Intangible assets

 

(71)

 

(91)

Vacation accrual and other

 

145

 

38

Valuation allowance

 

(36,765)

 

(27,714)

Total

$

$

Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the statutory tax rate to the effective tax rate is as follows:

    

Years Ended

June 30, 

    

2022

2021

Statutory federal income tax rate

 

21

%  

21

%

Change related to iBio CDMO

 

(3)

%  

%

Change in valuation allowance

 

(18)

%  

(21)

%

Effective income tax rate

 

%  

%